Literature DB >> 15078800

High-density lipoproteins neutralize C-reactive protein proinflammatory activity.

Carol Wadham1, Nathaniel Albanese, Jane Roberts, Lijun Wang, Christopher J Bagley, Jennifer R Gamble, Kerry-Anne Rye, Philip J Barter, Mathew A Vadas, Pu Xia.   

Abstract

BACKGROUND: C-reactive protein (CRP), a well-recognized marker of atherosclerosis, has recently been suggested to have a direct proinflammatory effect. The constitutive expression of low levels of CRP in normal plasma suggests the likelihood that a natural factor exists to neutralize the effect of CRP. This factor(s) has not yet been identified. Method and Results- The proinflammatory effect of CRP was measured by the induction of inflammatory adhesion molecules in human umbilical vein endothelial cells (HUVECs). We show that CRP significantly induced upregulation of adhesion molecules in both protein and mRNA levels. The CRP-induced expression of these inflammatory adhesion molecules was completely suppressed when the cells were preincubated with a physiological concentration (1 mg/mL apolipoprotein A-I) of HDLs derived from human plasma (native HDL) or reconstituted HDL (rHDL) at a very low concentration (0.01 mg/mL apolipoprotein A-I). A novel mechanism of HDL inhibition is likely to operate, because (1) rHDL was 100 times more potent than native HDL, (2) preincubation with HDL and its sustained presence were obligatory, and (3) oxidized 1-palmitoyl-2-linoleoyl-sn-glycero-3-phosphocholine was the fundamental active component.
CONCLUSIONS: The CRP-induced upregulation of inflammatory adhesion molecules in HUVECs was completely prevented by HDL via their oxidized phospholipid components.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15078800     DOI: 10.1161/01.CIR.0000127419.45975.26

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  29 in total

Review 1.  Systemic lupus erythematosus and cardiovascular disease: prediction and potential for therapeutic intervention.

Authors:  Maureen McMahon; Bevra H Hahn; Brian J Skaggs
Journal:  Expert Rev Clin Immunol       Date:  2011-03       Impact factor: 4.473

2.  Apolipoprotein A-I and cholesterol efflux: the good, the bad, and the modified.

Authors:  Ali Javaheri; Daniel J Rader
Journal:  Circ Res       Date:  2014-05-23       Impact factor: 17.367

3.  Identification of a novel virulence determinant with serum opacification activity in Streptococcus suis.

Authors:  Christoph G Baums; Ute Kaim; Marcus Fulde; Girish Ramachandran; Ralph Goethe; Peter Valentin-Weigand
Journal:  Infect Immun       Date:  2006-11       Impact factor: 3.441

Review 4.  Apolipoprotein A-I and its mimetics for the treatment of atherosclerosis.

Authors:  Jonathan D Smith
Journal:  Curr Opin Investig Drugs       Date:  2010-09

5.  5A, an apolipoprotein A-I mimetic peptide, attenuates the induction of house dust mite-induced asthma.

Authors:  Xianglan Yao; Cuilian Dai; Karin Fredriksson; Pradeep K Dagur; J Philip McCoy; Xuan Qu; Zu-Xi Yu; Karen J Keeran; Gayle J Zywicke; Marcelo J A Amar; Alan T Remaley; Stewart J Levine
Journal:  J Immunol       Date:  2010-11-29       Impact factor: 5.422

6.  Synovial fluid proteins differentiate between the subtypes of juvenile idiopathic arthritis.

Authors:  Margalit E Rosenkranz; David C Wilson; Anthony D Marinov; Alisha Decewicz; Patrick Grof-Tisza; David Kirchner; Brendan Giles; Paul R Reynolds; Michael N Liebman; V S Kumar Kolli; Susan D Thompson; Raphael Hirsch
Journal:  Arthritis Rheum       Date:  2010-06

7.  Arsenic Exposure and Subclinical Endpoints of Cardiovascular Diseases.

Authors:  Fen Wu; Peter Molinaro; Yu Chen
Journal:  Curr Environ Health Rep       Date:  2014-06-01

8.  Lipid abnormalities in a never-treated HIV-1 subtype C-infected African population.

Authors:  Carla Maria T Fourie; Johannes M Van Rooyen; Annamarie Kruger; Aletta E Schutte
Journal:  Lipids       Date:  2009-11-15       Impact factor: 1.880

Review 9.  CRP and the risk of atherosclerotic events.

Authors:  Paolo Calabrò; Enrica Golia; Edward T H Yeh
Journal:  Semin Immunopathol       Date:  2009-05-05       Impact factor: 9.623

Review 10.  Atherosclerosis and systemic lupus erythematosus: mechanistic basis of the association.

Authors:  Maureen McMahon; Bevra H Hahn
Journal:  Curr Opin Immunol       Date:  2007-12       Impact factor: 7.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.